Perhexiline maleate-induced hepatitis.

Area of Science:

• Hepatology
• Pharmacology
• Toxicology

Background:

• Perhexiline maleate is a medication used for angina.
• Long-term use can lead to adverse effects.
• Hepatotoxicity is a potential concern.

Observation:

• A patient experienced significant weight loss (29 kg).
• Hepatitis developed during perhexiline maleate therapy.
• Symptoms improved upon drug cessation.

Findings:

• Electron microscopy revealed characteristic inclusion bodies.
• Impaired hydroxylation capacity was observed.
• These findings suggest a metabolic disorder in pathogenesis.

Implications:

• This case highlights perhexiline maleate's potential for drug-induced liver injury.
• Metabolic pathways may play a crucial role in perhexiline toxicity.
• Further research into metabolic mechanisms of drug-induced hepatitis is warranted.